Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Brain, Behavior, & Immunity - Health|January 17, 2022
Neurocognitive Performance in Depressed Patients with low-grade inflammation and somatic symptomsMuzaffer Kaser, Éimear M Foley, Golam M Khandaker
Comprehensive Psychoneuroendocrinology|November 3, 2021
Clinical phenotypes of depressed patients with evidence of inflammation and somatic symptomsÉimear M Foley, Joel T Parkinson, Nils Kappelmann, et al.
Therapeutic Advances in Musculoskeletal Disease|November 23, 2020
Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and managementJoel T Parkinson, Éimear M Foley, Deepak R Jadon, et al.
Molecular Psychiatry|December 28, 2022
Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysisÉimear M Foley, Joel T Parkinson, Ruth E Mitchell, et al.
Psychoneuroendocrinology|March 5, 2024
A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depressionÉimear M Foley, Chloe Slaney, Nicholas A Donnelly, et al.
Brain, Behavior, and Immunity|May 15, 2025
Blood immuno-metabolic biomarker signatures of depression and affective symptoms in young adultsNicholas A Donnelly, Ruby S M Tsang, Éimear M Foley, et al.
JAMA Psychiatry|May 20, 2026
Interleukin 6 as a Treatment Target for Depression: A Proof-of-Concept Randomized Clinical TrialÉimear M Foley, Nicholas Turner, Ruta Margelyte, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Role of Inflammation in Depressive and Anxiety Disorders, Affect, and Cognition: Genetic and Non-Genetic Findings in the Lifelines Cohort StudyNaoise Mac Giollabhui, Chloe Slaney, Gibran Hemani, et al.
Translational Psychiatry|May 10, 2025
Role of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the lifelines cohort studyNaoise Mac Giollabhui, Chloe Slaney, Gibran Hemani, et al.
BMJ Open|March 24, 2023
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosisÉimear M Foley, Sian Lowri Griffiths, Alexander Murray, et al.
Pageof 2